Abbreviation: J. Infect. Dis. Immun.
Start Year: 2009
Published Articles: 75
https://doi.org/10.5897/JIDI2017.0174[Article Number: F7BBC0656012]
Antiretroviral therapy has reduced HIV-related morbidity and mortality substantially. WHO recommends the use of Nevirapine or Efavirenz as first line combined with two from nucleoside reverse transcriptase inhibitors. In this study the immunological outcomes of Neverapin versus Efafrenz based ART was assessed. Medical records of patients were retrieved and important variables were captured to standard questionnaire.... Read more.